Protagenic Therapeutics (PTIX) Shares Phase 1 Study Results for PT00114 - GuruFocus4 days ago • Google News
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice - Naples Daily News5 days ago • Google News